Article Information
History
- June 16, 2021.
Article Versions
- Version 1 (December 22, 2020 - 17:56).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Jobin John Jacob1,†,
- Karthick Vasudevan1,4,†,
- Agila Kumari Pragasam1,
- Karthik Gunasekaran2,
- Balaji Veeraraghavan1,* and
- Ankur Mutreja3,*
- 1Department of Clinical Microbiology, Christian Medical College, Vellore, India
- 2Department of General Medicine (Unit-V), Christian Medical College, Vellore, India
- 3Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID) Department of Medicine, University of Cambridge, Cambridge, UK
- 4Department of Biotechnology, School of Applied Sciences, REVA University, Bangalore, India
- ↵*Address correspondence
to Dr Ankur Mutreja, Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID) Department of Medicine, University of Cambridge, Cambridge, UK, Tel: +44 - 1223-336512, Email: am872{at}medschl.cam.ac.uk, Correspondence may also be addressed to:
Dr Balaji Veeraraghavan, Department of Clinical Microbiology, Christian Medical College, Vellore, India, Tel: +91 94422 10555, Email: vbalaji{at}cmcvellore.ac.in
↵† Contributions: Jobin John Jacob and Karthick Vasudevan contributed equally to this manuscript
Posted June 16, 2021.
Evolutionary tracking of SARS-CoV-2 genetic variants highlights an intricate balance of stabilizing and destabilizing mutations
